Impact of Dose Selection Strategies Used in Phase II on the Probability of Success in Phase III
Authors:
- Zoran AntonijevicZAZoran Antonijevic
- José PinheiroJPJosé Pinheiro
- Parvin FardipourPFParvin Fardipour
- Roger J. LewisRLRoger J. Lewis
- 1 November 2010
- journal article
- Published by Taylor & Francis in Statistics in Biopharmaceutical Research
- Vol. 2 (4) , 469-486
Abstract
The purpose of this study was to assess the impact of phase II dose-selection strategies on the likelihood of success of phase III clinical programs, comparing both traditional and adaptive approac...Keywords
This publication has 9 references indexed in Scilit:
- A Perspective on Characterizing Benefits and Risks Derived from Clinical Trials: Can We Do More?Drug Information Journal, 2008
- Adaptive dose finding based on t‐statistic for dose–response trialsStatistics in Medicine, 2008
- Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging TrialsJournal of Biopharmaceutical Statistics, 2007
- Discussion of “The White Paper of the PhRMA Working Group on Adaptive Dose-Ranging Designs”Journal of Biopharmaceutical Statistics, 2007
- Adaptive designs for dose-finding based on efficacy–toxicity responseJournal of Statistical Planning and Inference, 2006
- Combining Multiple Comparisons and Modeling Techniques in Dose‐Response StudiesBiometrics, 2005
- ASTIN: a Bayesian adaptive dose–response trial in acute strokeClinical Trials, 2005
- Prospective validation of clinically important changes in pain severity measured on a visual analog scaleAnnals of Emergency Medicine, 2001
- A Multiple Comparison Procedure for Comparing Several Treatments with a ControlJournal of the American Statistical Association, 1955